Tag: Cardiac implants

FDA issues Class 1 recall for vascular cannulas

Editor's Note Aortic root cannulas from Medtronic are the subject of the latest US Food and Drug Administration (FDA) class 1 recall, the most serious category reserved for risk of injury or death. Affected products include the DLP Aortic Root Cannula, MiAR Cannula, and DLP Aortic Root Cannula with Vent…

Read More

By: Matt Danford
April 1, 2025
Share

Study: Miniature pacemakers for neonates, infants perform reliably for two years

Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…

Read More

By: Matt Danford
March 17, 2025
Share

Man survives 100 days with artificial titanium heart, setting new milestone

Editor's Note An Australian man lived for 100 days with an artificial titanium heart, the longest duration recorded for a patient using the device, according to a March 12 report from CNN. The breakthrough marks a significant step toward using total artificial hearts as a long-term solution for patients with…

Read More

By: Matt Danford
March 13, 2025
Share

FDA designates Class 1 recall for pacemakers

Editor’s Note The US Food and Drug Administration (FDA) has designated Boston Scientific Corporation’s recall of Accolade Pacemaker devices a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s February 21 announcement, the recall was motivated by a manufacturing issue that could…

Read More

By: Matt Danford
February 24, 2025
Share

Study: Mechanical heart valves outperform biological for long-term survival in middle-aged patients

Editor's Note Patients aged 50 to 70 undergoing heart valve replacement may benefit from mechanical valves over biological ones, according to a new study from the University of Bristol. Healthcare-in-Europe.com reported the news February 13. As detailed in the article, short-term outcomes between the two options were similar. However, mechanical…

Read More

By: Matt Danford
February 14, 2025
Share

CABG, TAVR drive hospital revenue despite cost variations

Editor's Note Coronary artery bypass graft (CABG) surgery and transcatheter aortic valve replacement (TAVR) generate the highest overall financial returns for US hospitals, despite not being the most profitable per procedure, according to a February 13 report in Cardiovascular Business. The article covers an analysis of Medicare data, published in…

Read More

By: Matt Danford
February 14, 2025
Share

Why active implants demand proactive management

What happens when a surgeon uses the monopolar instrument set on 30-W coagulation mode to create an upper midline incision in a patient with a pacemaker? Pacemaker function is interrupted, causing a heart block that results in hemodynamic instability—or at least, this is what could happen without taking the necessary…

Read More

By: Mary A. Marvin, APRN-BC and Jill Teubel, MSN, RN
January 1, 2025
Share

Heart pump recall, lack of donor organs create concern for heart failure patients

Editor's Note The lack of available hearts for transplantation combined with the recent recall of Abbott’s HeartMate 3 left ventricular assist device (LVAD) “makes the current therapy landscape for heart failure much more dire,” according to a May 20 report in Medical Device Network. The recall of the device, which…

Read More

By: Matt Danford
May 20, 2024
Share

Long-lasting heart valves poised to set world record

Editor's Note More than 45 years after surgery, Mary Ann Kozlowski’s mechanical heart valves are still pumping—and Guinness is reviewing an application to list her as the new world record-holder for longevity of a double-valve replacement. That’s according to a May 15 report in the Erie-Times News, which detailed how…

Read More

By: Matt Danford
May 17, 2024
Share

FDA Class 1 recall renews concern about historically problematic heart pumps

The US Food & Drug Administration (FDA) announced a Class 1 recall on Monday for Abbott/Thoratec Corp.’s HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due due to biological material buildup obstructing the devices. According to an April 16 CBS News report, surgeons first noticed problems with the…

Read More

By: Matt Danford
April 17, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat